Table 1.
Correlation between CD8+ TEX-related prognostic risk score and clinicopathologic features in patients with HCC
| Characteristic | Total (N) | Risk Score | Statistic | P-value | |
|---|---|---|---|---|---|
| Low (n = 184) | High (n = 181) | ||||
| Gender, n (%) | 365 | ||||
| Female | 119 | 59 (16.2%) | 60 (16.4%) | 0.01 | 0.913 |
| Male | 246 | 125 (34.2%) | 121 (33.2%) | ||
| Age, n (%) | 365 | ||||
| < = 60 | 173 | 81 (22.2%) | 92 (25.2%) | 1.43 | 0.231 |
| > 60 | 192 | 103 (28.2%) | 89 (24.4%) | ||
| BMI, n (%) | 332 | ||||
| < = 25 | 175 | 79 (23.8%) | 96 (28.9%) | 3.96 | 0.047 |
| > 25 | 157 | 89 (26.8%) | 68 (20.5%) | ||
| AFP(ng/ml), n (%) | 276 | ||||
| < = 400 | 213 | 123 (44.6%) | 90 (32.6%) | 7.97 | 0.005 |
| > 400 | 63 | 23 (8.3%) | 40 (14.5%) | ||
| Child–Pugh grade, n (%) | 237 | ||||
| A | 216 | 121 (51.1%) | 95 (40.1%) | 0.01 | 0.928 |
| B | 21 | 11 (4.6%) | 10 (4.2%) | ||
| T stage, n (%) | 362 | ||||
| T1 | 180 | 109 (30.1%) | 71 (19.6%) | 16.93 | < 0.001 |
| T2 | 91 | 39 (10.8%) | 52 (14.4%) | ||
| T3 | 78 | 29 (8%) | 49 (13.5%) | ||
| T4 | 13 | 4 (1.1%) | 9 (2.5%) | ||
| Histologic grade, n (%) | 360 | ||||
| G1 | 55 | 35 (9.7%) | 20 (5.6%) | 15.17 | 0.002 |
| G2 | 175 | 96 (26.7%) | 79 (21.9%) | ||
| G3 | 118 | 48 (13.3%) | 70 (19.4%) | ||
| G4 | 12 | 2 (0.6%) | 10 (2.8%) | ||
| Pathologic stage, n (%) | 341 | ||||
| Stage I | 170 | 105 (30.8%) | 65 (19.1%) | — | < 0.001 |
| Stage II | 84 | 38 (11.1%) | 46 (13.5%) | ||
| Stage III | 83 | 27 (7.9%) | 56 (16.4%) | ||
| Stage IV | 4 | 3 (0.9%) | 1 (0.3%) | ||
| Vascular invasion, n (%) | 311 | ||||
| No | 106 | 45 (14.5%) | 61 (19.6%) | 7.06 | 0.008 |
| Yes | 205 | 121 (38.9%) | 84 (27%) | ||